0 results for 'Anapol Schwartz'
Innovator Liability Approach in Pharmaceutical Litigation
One of the first questions I ask potential clients in pharmaceutical litigation is whether they took the name brand of the drug or the generic version, as I know under the current law in most states they will only have an actionable claim if they took the name brand. This limitation originates from the U.S. Supreme Court's ruling in , 131 S.Ct. 2567 (2011).At Trial, Gay Lawyer's Ex-Boss Says He Was Betrayed
Mark LeWinter, who supervised Jeffrey Downs, the gay attorney suing Anapol Schwartz for defamation, testified Wednesday his trust had been "betrayed" when Downs told another firm leader to keep LeWinter in the dark about Downs' threat of a lawsuit.At Trial, Gay Lawyer's Ex-Boss Says He Was Betrayed
Mark LeWinter, who supervised Jeffrey Downs, the gay attorney suing Anapol Schwartz for defamation, testified Wednesday his trust had been "betrayed" when Downs told another firm leader to keep LeWinter in the dark about Downs' threat of a lawsuit.Gay Lawyer Takes Stand in Defamation Suit
The gay attorney suing Anapol Schwartz for defamation took the stand Tuesday to outline his departure from the firm and decision to accept a job at Raynes McCarty.Gay Lawyer Takes Stand in Defamation Suit
The gay attorney suing Anapol Schwartz for defamation took the stand Tuesday to outline his departure from the firm and decision to accept a job at Raynes McCarty.Philadelphia Defamation Trial Begins for Gay Lawyer Suing Firms
Attorneys offered opening statements Monday afternoon in the state-court defamation case of the gay lawyer who claimed two law firms scuttled his lateral move.Philadelphia Defamation Trial Begins for Gay Lawyer Suing Firms
Attorneys offered opening statements Monday afternoon in the state-court defamation case of the gay lawyer who claimed two law firms scuttled his lateral move.FDA Poised to Enact Rule That Will Advance Consumer Safety
On March 27, the U.S. Food and Drug Administration held a public meeting regarding its proposed generic-drug labeling rule. The rule proposed by the FDA in November 2013, titled "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products," would allow a generic manufacturer to use the CBE-0 process to implement a safety-related labeling change for its drug unilaterally, prior to the FDA approving the label change.FDA Poised to Enact Rule That Will Advance Consumer Safety
On March 27, the U.S. Food and Drug Administration held a public meeting regarding its proposed generic-drug labeling rule. The rule proposed by the FDA in November 2013, titled "Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products," would allow a generic manufacturer to use the CBE-0 process to implement a safety-related labeling change for its drug unilaterally, prior to the FDA approving the label change.Supreme Court Won't Rule on Zappala's Dragonetti Appeal
The Pennsylvania Supreme Court has dismissed as being improvidently granted an appeal brought in a suit against several law firms by the former co-owner of the juvenile detention facility at the heart of the Luzerne County "kids-for-cash" judicial scandal.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
The 2024 Benchmark of Ethical Culture Report
Brought to you by LRN
Download Now
State Lawmakers Targeting Plastic Pollution in 2024
Brought to you by LexisNexis®
Download Now
Leveraging Technology to Increase Law Firm Profitability
Brought to you by Tranch
Download Now
Blueprint for Successful Second Request Document Review
Brought to you by Integreon
Download Now